Request for Information: STI National Strategic Plan 2021-2025 Available for Public Comment, 59321-59322 [2020-20677]

Download as PDF Federal Register / Vol. 85, No. 183 / Monday, September 21, 2020 / Notices 2012, respectively.2 Human papillomavirus (HPV), the most common STI, accounts for 14 million new STI infections each year.3 Left untreated, STIs can lead to significant health consequences. To spur action to reduce STI rates and their adverse public health impact, OASH through OIDP, in collaboration with federal partners throughout HHS and other departments, led and coordinated development of the inaugural STI Plan. Opportunities for public input were provided, and public Dated: September 16, 2020. comments received were reviewed, and Lauren K. Roth, analyzed and helped inform the Associate Commissioner for Policy. components of the STI Plan. [FR Doc. 2020–20801 Filed 9–18–20; 8:45 am] The STI Plan is intended to serve as BILLING CODE 4164–01–P a roadmap for all stakeholders at all levels to guide development of policies, initiatives, and actions for STI DEPARTMENT OF HEALTH AND prevention and control. The STI Plan HUMAN SERVICES focuses on four of the STIs that have the greatest impact on the health of the Request for Information: STI National nation: chlamydia, gonorrhea, syphilis, Strategic Plan 2021–2025 Available for and HPV. However, most of its Public Comment components are also applicable to other prevalent STIs. AGENCY: Office of the Secretary, The STI Plan presents a strategic Department of Health and Human framework for integrating and Services. leveraging synergistic policies, ACTION: Notice. programs, and resources. It sets forth a SUMMARY: The Department of Health and vision and goals for the nation, with objectives and strategies for each goal. Human Services (HHS) Office of Infectious Disease and HIV/AIDS Policy The objectives and strategies offered in this plan are interrelated and may be (OIDP) in the Office of the Assistant Secretary for Health (OASH) announces used to make progress toward more than one goal. The STI Plan identifies the draft Sexually Transmitted Infections National Strategic Plan 2021– priority populations (i.e., those populations disproportionately 2025 (STI Plan) available for public impacted by STIs based on national comment. The draft STI Plan may be data) to guide national efforts to realize reviewed at www.hhs.gov/STI. the highest impact on reducing STIs. DATES: All comments must be received The STI Plan also includes indicators to by 5:00 p.m. ET on October 1, 2020 to measure progress and quantitative ensure consideration. targets for each indicator. Although it is ADDRESSES: All comments must be a 5-year plan, it sets 10-year quantitative submitted electronically to STDPlan@ targets for each indicator—reflecting the hhs.gov. reality that it will take more than 5 years FOR FURTHER INFORMATION CONTACT: to reverse, not just slow, the upward Carol Jimenez, OIDP, Carol.Jimenez@ trajectory of rising STI rates, and to hhs.gov, 202–401–5131. eliminate the epidemic. The order in SUPPLEMENTARY INFORMATION: Persistent which the goals, objectives, strategies, rises in the rates of sexually transmitted and indicators are presented is not infections (STIs) in the United States associated with any prioritization. The following are the STI Plan’s constitute an epidemic and public health crisis with profound implications vision and goals. Vision: The United States will be a place where sexually for all Americans. In recent decades, transmitted infections are prevented and rates of chlamydia, gonorrhea, syphilis, where every person has high-quality STI congenital syphilis, and human prevention, care, and treatment while papillomavirus have increased significantly. The rate of chlamydia, the living free from stigma and most prevalent STI, increased by greater discrimination. This vision includes all people, regardless of age, sex, gender than 200% from 2011 to 2018.1 In just over a decade, the rate of gonorrhea rose identity, sexual orientation, race, by greater than 80% from a historic low. ethnicity, disability, geographic location, or socioeconomic The rates of primary and secondary circumstance. Goals: syphilis and of congenital syphilis 1. Prevent new STIs increased every year since 2001 and jbell on DSKJLSW7X2PROD with NOTICES treatment of hospitalized patients with COVID–19. Given the issuance of this EUA, FDA is issuing a new guidance of the same title that provides recommendations and additional information related to the EUA for the use of COVID–19 convalescent plasma to treat hospitalized patients with COVID–19. The new guidance supersedes the May 2020 guidance. Elsewhere in this issue of the Federal Register, FDA is announcing the availability of the new guidance. VerDate Sep<11>2014 19:59 Sep 18, 2020 Jkt 250001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 59321 2. Improve the health of people by reducing adverse outcomes of STIs 3. Accelerate progress in STI research, technology, and innovation 4. Reduce STI-related health disparities and health inequities 5. Achieve integrated, coordinated efforts that address the STI epidemic A roadmap for stakeholders at all levels and sectors, the STI Plan envisions a whole-of-nation response to preventing and controlling STIs in the United States. The STI Plan assumes the active participation of state, local, and tribal health departments and organizations, health plans and health care providers, schools and other academic institutions, community- and faith-based organizations, scientists, researchers, and the public in this effort. The priority populations, indicators, and quantitative targets, especially the methods used to determine them, are intended to help focus efforts and limited resources to realize the most impact. Stakeholders are encouraged to focus on activities that resonate the most with the needs of the populations they serve and services they provide, and, using the STI Plan as a framework, develop their own plans to reverse the rise of STIs and improve the health of their communities, states, tribal nations, and the nation. Information Needs The draft STI Plan may be reviewed at: www.hhs.gov/STI. OIDP seeks to obtain feedback from external stakeholders on the following: 1. Do the draft plan’s goals, objectives, and strategies appropriately address the STI epidemic? 2. Are there any critical gaps in the STI Plan’s goals, objectives, and strategies? If so, please specify the gaps. 3. Do any of the STI Plan’s goals, objectives and strategies cause concern? If so, please specify the goal, objective or strategy, and describe the concern regarding it. Please be succinct and limit your comments to a maximum of seven pages. Authority: 77 FR 15761 (March 16, 2012). Dated: September 15, 2020. B. Kaye Hayes, Acting Director, Office of Infectious Disease and HIV/AIDS Policy. Footnotes 1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018. U.S. Department of Health and Human Services; 2019. Accessed June 22, 2020. https://www.cdc.gov/std/ E:\FR\FM\21SEN1.SGM 21SEN1 59322 Federal Register / Vol. 85, No. 183 / Monday, September 21, 2020 / Notices stats18/STDSurveillance2018-fullreport.pdf 2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018. U.S. Department of Health and Human Services; 2019. Accessed June 22, 2020. https://www.cdc.gov/std/ stats18/STDSurveillance2018-fullreport.pdf 3. About HPV. Centers for Disease Control and Prevention. Accessed July 14, 2020. https://www.cdc.gov/hpv/ parents/about-hpv.html [FR Doc. 2020–20677 Filed 9–18–20; 8:45 am] BILLING CODE 4150–43–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [Docket No. USCBP–2020–0053] Commercial Customs Operations Advisory Committee (COAC); Meeting U.S. Customs and Border Protection (CBP), Department of Homeland Security (DHS). ACTION: Committee Management; notice of Federal Advisory Committee meeting. AGENCY: The Commercial Customs Operations Advisory Committee (COAC) will hold its quarterly meeting on Wednesday, October 7, 2020. The meeting will be open to the public via webinar only. There is no on-site, inperson option for this quarterly meeting. DATES: The COAC will meet on Wednesday, October 7, 2020, from 1:00 p.m. to 5:00 p.m. EDT. Please note that the meeting may close early if the committee has completed its business. Comments must be submitted in writing no later than October 6, 2020. ADDRESSES: The meeting will be held via webinar. The webinar link and conference number will be provided to all registrants by 10:00 a.m. EDT on October 7, 2020. For information on facilities or services for individuals with disabilities or to request special assistance at the meeting, contact Ms. Florence Constant-Gibson, Office of Trade Relations, U.S. Customs and Border Protection (CBP), at (202) 344– 1440, as soon as possible. FOR FURTHER INFORMATION CONTACT: Ms. Florence Constant-Gibson, Office of Trade Relations, U.S. Customs and Border Protection, 1300 Pennsylvania Avenue NW, Room 3.5A, Washington, DC 20229; telephone (202) 344–1440; or Ms. Valarie Neuhart, Deputy Executive Director and Designated Federal Officer, at (202) 344–1440. jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:59 Sep 18, 2020 Jkt 250001 Notice of this meeting is given under the authority of the Federal Advisory Committee Act, 5 U.S.C. Appendix. The Commercial Customs Operations Advisory Committee (COAC) provides advice to the Secretary of Homeland Security, the Secretary of the Treasury, and the Commissioner of U.S. Customs and Border Protection (CBP) on matters pertaining to the commercial operations of CBP and related functions within the Department of Homeland Security and the Department of the Treasury. Pre-registration: For members of the public who plan to participate via webinar, please register online at https://teregistration.cbp.gov/ index.asp?w=211 by 5:00 p.m. EDT by October 6, 2020. For members of the public who are pre-registered to attend the webinar and later need to cancel, please do so by October 6, 2020, utilizing the following link: https:// teregistration.cbp.gov/ cancel.asp?w=211. Please feel free to share this information with other interested members of your organization or association. To facilitate public participation, we are inviting public comment on the issues the committee will consider prior to the formulation of recommendations as listed in the Agenda section below. Comments must be submitted in writing no later than October 6, 2020, and must be identified by Docket No. USCBP–2020–0053, and may be submitted by one (1) of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Email: tradeevents@cbp.dhs.gov. Include the docket number in the subject line of the message. • Mail: Ms. Florence ConstantGibson, Office of Trade Relations, U.S. Customs and Border Protection, 1300 Pennsylvania Avenue NW, Room 3.5A, Washington, DC 20229. Instructions: All submissions received must include the words ‘‘Department of Homeland Security’’ and the docket number (USCBP–2020–0053) for this action. Comments received will be posted without alteration at https:// www.regulations.gov. Please do not submit personal information to this docket. Docket: For access to the docket or to read background documents or comments, go to https:// www.regulations.gov and search for Docket Number USCBP–2020–0053. To submit a comment, click the ‘‘Comment Now!’’ button located on the top-right hand side of the docket page. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 There will be multiple public comment periods held during the meeting on October 7, 2020. Speakers are requested to limit their comments to two (2) minutes or less to facilitate greater participation. Please note that the public comment period for speakers may end before the time indicated on the schedule that is posted on the CBP web page, https://www.cbp.gov/trade/ stakeholder-engagement/coac. Agenda The COAC will hear from the current subcommittees on the topics listed below and then will review, deliberate, provide observations, and formulate recommendations on how to proceed: 1. The Intelligent Enforcement Subcommittee will discuss its White Paper on Enforcement Modernization to support CBP’s 21st Century Customs Framework, which aims to further improve risk management and the impact of efforts to detect high-risk activity, deter non-compliance, and disrupt fraudulent behavior by better utilizing technology, big data, and predictive analysis to drive decisionmaking. The subcommittee also will discuss prioritized past recommendations and any new recommendations from the AntiDumping/Countervailing Duty (AD/ CVD), Bond, Intellectual Property Rights (IPR), and Forced Labor Working Groups. The Forced Labor Working Group will present recommendations on CBP’s existing forced labor allegations submission mechanisms including the e-Allegations web portal. 2. The Secure Trade Lanes Subcommittee will provide updates on the Trusted Trader Working Group’s activities specific to the CTPAT Trade Compliance program enhancements including benefits, Participating Government Agency engagement, and forced labor. The Export Modernization Working Group will provide updates and recommendations focusing on improving current export processes. The subcommittee will also report on the activities of the Remote and Autonomous Cargo Processing Working Group. 3. The Next Generation Facilitation Subcommittee will provide an update on the progress of the One U.S. Government Working Group with Partner Government Agencies regarding advancement in Trusted Trader initiatives. There will be an update on the progress of the Unified Entry Processing Working Group’s operational framework. Finally the Emerging Technologies Working Group will provide an assessment of various technologies evaluated this past quarter E:\FR\FM\21SEN1.SGM 21SEN1

Agencies

[Federal Register Volume 85, Number 183 (Monday, September 21, 2020)]
[Notices]
[Pages 59321-59322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-20677]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Request for Information: STI National Strategic Plan 2021-2025 
Available for Public Comment

AGENCY: Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) Office of 
Infectious Disease and HIV/AIDS Policy (OIDP) in the Office of the 
Assistant Secretary for Health (OASH) announces the draft Sexually 
Transmitted Infections National Strategic Plan 2021-2025 (STI Plan) 
available for public comment. The draft STI Plan may be reviewed at 
www.hhs.gov/STI.

DATES: All comments must be received by 5:00 p.m. ET on October 1, 2020 
to ensure consideration.

ADDRESSES: All comments must be submitted electronically to 
[email protected].

FOR FURTHER INFORMATION CONTACT: Carol Jimenez, OIDP, 
[email protected], 202-401-5131.

SUPPLEMENTARY INFORMATION: Persistent rises in the rates of sexually 
transmitted infections (STIs) in the United States constitute an 
epidemic and public health crisis with profound implications for all 
Americans. In recent decades, rates of chlamydia, gonorrhea, syphilis, 
congenital syphilis, and human papillomavirus have increased 
significantly. The rate of chlamydia, the most prevalent STI, increased 
by greater than 200% from 2011 to 2018.\1\ In just over a decade, the 
rate of gonorrhea rose by greater than 80% from a historic low. The 
rates of primary and secondary syphilis and of congenital syphilis 
increased every year since 2001 and 2012, respectively.\2\ Human 
papillomavirus (HPV), the most common STI, accounts for 14 million new 
STI infections each year.\3\ Left untreated, STIs can lead to 
significant health consequences.
    To spur action to reduce STI rates and their adverse public health 
impact, OASH through OIDP, in collaboration with federal partners 
throughout HHS and other departments, led and coordinated development 
of the inaugural STI Plan. Opportunities for public input were 
provided, and public comments received were reviewed, and analyzed and 
helped inform the components of the STI Plan.
    The STI Plan is intended to serve as a roadmap for all stakeholders 
at all levels to guide development of policies, initiatives, and 
actions for STI prevention and control. The STI Plan focuses on four of 
the STIs that have the greatest impact on the health of the nation: 
chlamydia, gonorrhea, syphilis, and HPV. However, most of its 
components are also applicable to other prevalent STIs.
    The STI Plan presents a strategic framework for integrating and 
leveraging synergistic policies, programs, and resources. It sets forth 
a vision and goals for the nation, with objectives and strategies for 
each goal. The objectives and strategies offered in this plan are 
interrelated and may be used to make progress toward more than one 
goal. The STI Plan identifies priority populations (i.e., those 
populations disproportionately impacted by STIs based on national data) 
to guide national efforts to realize the highest impact on reducing 
STIs. The STI Plan also includes indicators to measure progress and 
quantitative targets for each indicator. Although it is a 5-year plan, 
it sets 10-year quantitative targets for each indicator--reflecting the 
reality that it will take more than 5 years to reverse, not just slow, 
the upward trajectory of rising STI rates, and to eliminate the 
epidemic. The order in which the goals, objectives, strategies, and 
indicators are presented is not associated with any prioritization.
    The following are the STI Plan's vision and goals. Vision: The 
United States will be a place where sexually transmitted infections are 
prevented and where every person has high-quality STI prevention, care, 
and treatment while living free from stigma and discrimination. This 
vision includes all people, regardless of age, sex, gender identity, 
sexual orientation, race, ethnicity, disability, geographic location, 
or socioeconomic circumstance. Goals:

1. Prevent new STIs
2. Improve the health of people by reducing adverse outcomes of STIs
3. Accelerate progress in STI research, technology, and innovation
4. Reduce STI-related health disparities and health inequities
5. Achieve integrated, coordinated efforts that address the STI 
epidemic

    A roadmap for stakeholders at all levels and sectors, the STI Plan 
envisions a whole-of-nation response to preventing and controlling STIs 
in the United States. The STI Plan assumes the active participation of 
state, local, and tribal health departments and organizations, health 
plans and health care providers, schools and other academic 
institutions, community- and faith-based organizations, scientists, 
researchers, and the public in this effort. The priority populations, 
indicators, and quantitative targets, especially the methods used to 
determine them, are intended to help focus efforts and limited 
resources to realize the most impact. Stakeholders are encouraged to 
focus on activities that resonate the most with the needs of the 
populations they serve and services they provide, and, using the STI 
Plan as a framework, develop their own plans to reverse the rise of 
STIs and improve the health of their communities, states, tribal 
nations, and the nation.

Information Needs

    The draft STI Plan may be reviewed at: www.hhs.gov/STI.
    OIDP seeks to obtain feedback from external stakeholders on the 
following:
    1. Do the draft plan's goals, objectives, and strategies 
appropriately address the STI epidemic?
    2. Are there any critical gaps in the STI Plan's goals, objectives, 
and strategies? If so, please specify the gaps.
    3. Do any of the STI Plan's goals, objectives and strategies cause 
concern? If so, please specify the goal, objective or strategy, and 
describe the concern regarding it.
    Please be succinct and limit your comments to a maximum of seven 
pages.

    Authority: 77 FR 15761 (March 16, 2012).

    Dated: September 15, 2020.
B. Kaye Hayes,
Acting Director, Office of Infectious Disease and HIV/AIDS Policy.

Footnotes

1. Centers for Disease Control and Prevention. Sexually Transmitted 
Disease Surveillance 2018. U.S. Department of Health and Human 
Services; 2019. Accessed June 22, 2020. https://www.cdc.gov/std/

[[Page 59322]]

stats18/STDSurveillance2018-full-report.pdf
2. Centers for Disease Control and Prevention. Sexually Transmitted 
Disease Surveillance 2018. U.S. Department of Health and Human 
Services; 2019. Accessed June 22, 2020. https://www.cdc.gov/std/stats18/STDSurveillance2018-full-report.pdf
3. About HPV. Centers for Disease Control and Prevention. Accessed July 
14, 2020. https://www.cdc.gov/hpv/parents/about-hpv.html

[FR Doc. 2020-20677 Filed 9-18-20; 8:45 am]
BILLING CODE 4150-43-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.